ESR1 and breast cancer: To decipher the molecular mechanisms that ER triggers upon ligand activation, estrogen-responding breast cancer cell lines, often MCF-7 that is widely used by ENCODE (6), are deprived of steroid stimuli for several days and re-stimulated with agonist E2, after which various readouts can be measured.